Abstract
hours. Aliquots of concentrated enzyme were flash frozen in liquid nitrogen and stored at -80 C.
7 9
Frozen samples maintained activity for at least six months.
8 0
The concentration of active enzyme was calculated with the ferrous carbon monoxide 1 8 1 (CO) versus ferrous difference spectrum (Guengerich et al. 2009 ). I added 10-20 μ l of 1 8 2 concentrated P450 to CO buffer (100 mM potassium phosphate buffer (pH 7.4), 1 mM EDTA, 1 8 3 20% glycerol, 0.5% sodium cholate, and 0.4% Triton N-1010) to a total volume of 1 ml. After 1 8 4 blanking with the P450 and buffer solution, CO was bubbled into the cuvette at 2 bubbles per 1 8 5 second for 45 seconds. A few milligrams of sodium dithionite powder is added to reduce the 1 8 6 CO-P450 complex and the cuvette was covered with parafilm and inverted ten times. In a 1 8 7 cuvette in the Nanodrop 2000c I scanned the spectra from 400 to 500 nm every thirty seconds 
9 3
Protein expression Reductases 1 9 4
The BL21(DE3) cells with FdX were grown overnight (100 ug/ml AMP in LB) and 5 ml of 1 9 5 overnight culture was added to 500 ml LB with no antibiotic at 37 C 210 rpm. When the OD 600 1 9 6 was 0.7, the cells were induced with 0.5 mM IPTG and grown at 30 C, 125 rpm for 24 hours 1 9 7 (Modified from (Uhlmann et al. 1992) ).
9 8
FdX containing cells were harvested via centrifugation 4000 x g for 25 minutes at 4 C.
9 9
The pellet was resuspended in 30 ml Buffer P (10 mM KPO4 pH 7.4, 1 mM EDTA, 1 mM PMSF, 2 0 0 30 ul lysozyme and DNaseI) from (Uhlmann et al. 1992 ) and homogenized with sonication as 2 0 1 outlined above for the P450 enzymes. The large cell debris was removed by centrifugation at 2 0 2 10,000 x g for 30 minutes at 4 C. AdX was enriched by adding ammonium sulfate to 60% at 4 C 2 0 3 followed by centrifugation at 45,995 g for 1 hour. The supernatant was dialyzed overnight with 2 0 4
Buffer P. The supernatant was passed through a 0.45μm filter, added to Source Q anion 2 0 5 exchange column (GE Healthcare Life Sciences) and eluted with a 0-400 mM NaCl gradient in 2 0 6
Buffer P. The brown fractions were concentrated and stored in 20% glycerol Buffer P. and 2 0 7 quantified in a nanodrop cuvette with the extinction coefficient of 9.8 mM -1 cM -1 at 415 nm.
0 8
The human FdxR was also expressed in pET17b and was co-expressed with GroEL/ES 2 0 9
in BL21(DE3). Cells were grown overnight (37 C, 225 rpm) and inoculated into 500 ml TB with 2 1 0 100 μ g/ml ampicillin and 50 μ g/ml kanamycin. At OD 600 of 0.5 FdxR was induced with 0.5 mM 2 1 1 9 IPTG and 4 mg/ml arabinose. After induction, the cells were grown at 26 C, 125 rpm shaking for 2 1 2 72 hours (modified from (Sagara et al. 1993) ).
1 3
Cells were harvested via centrifugation 4000 x g for 25 minutes at 4C and resuspend in 2 1 4 30 ml Buffer P (10 mM KPO4 pH 7.4, 1 mM EDTA, 1 mM PMSF, 30 ul lysozyme and DNaseI).
1 5
The cells were homogenized via sonication as described above. The cell debris was removed 2 1 6
by centrifugation at 45,995 x g for 1 hour at 4 C. The supernatant was dialyzed overnight with 2 1 7
Buffer P, and applied to a Source Q anion exchange column after filtration through a 0.45 2 1 8 micron filter. The flow through was collected and applied to a 2'5'-ADP-Sepharose column. The 2 1 9
column was washed with Buffer P and the protein eluted with a 0-400 mM NaCl gradient in 2 2 0
Buffer P. The flow through on the 2'5'-ADP Sepharose column was reapplied to obtain more 2 2 1
FdxR. Yellow fractions were collected, concentrated and stored in 20% glycerol Buffer P. FdxR 2 2 2 was quantified using the extinction coefficient 10.9 mM -1 cM -1 at 450 nm in Buffer P.
3
Cytochrome P450 kinetic assays 2 2 4
To quantify the specific activity (μmol min -1 mg -1 ) of the CYP11B homologs, I combined We studied a duplication followed by functional divergence in the corticosteroid pathway 2 4 9 in primates. As previously reported (Baker, Nelson, and Studer 2015) , I found at least three 2 5 0 independent duplications of CYP11B in mammals ( Figure S1 ). Here I focus on the duplication 2 5 1
and subsequent functional shift that occurred in the primate lineage ( Figure 2 ). The phylogenetic 2 5 2 evidence is nearly equivocal on whether the gene duplication occurred before or after the split of 2 5 3
Old World primates (parvorder Catarrhini) and New World monkeys (parvorder Platyrrhini), with 2 5 4
the ML tree weakly supporting the duplication occurring before this split, and a more 2 5 5
parsimonious hypothesis of gene gain and loss favoring the duplication occurring after this split.
5 6
Of the New World monkeys for which I found sequences, the black-capped squirrel The CYP11B paralogs in humans have functionally diverged following duplication.
6 5
CYP11B increased its ability to produce either cortisol and corticosterone (11β-hydroxylation 2 6 6 products) and most of its ability to produce aldosterone ( Figure 3 ) (consistent with previous 2 6 7 studies (Zöllner et al. 2008; Hobler et al. 2012; Strushkevich et al. 2013) ). These results agree 2 6 8 with these previous studies except that I detected a small amount of 18-hydroxycorticosterone 2 6 9
and aldosterone produced by CYP11B1 in vitro ( Figure 3 ).
7 0
The human CYP11B2 paralog has increased ability to produce both 11β-hydroxylation 2 7 1 products and 18-oxidation products (aldosterone) (Figure 3 ). 11β-hydroxylation function is 2 7 2 always higher than 18-oxidation function and both paralogs retain the ability to complete both 2 7 3
11β-and 18-oxidation.
7 4
Function of ancestral CYP11B, CYP11B1, and CYP11B2
7 5
The pre-duplication ancestor of CYP11B1 and CYP11B2, AncCYP11B, had moderate 2 7 6
18-oxidation activity and relatively low 11β-hydroxylation activity in vitro (Fig 3) hydroxylation. The AncCYP11B2 and the extant human CYP11B2 both maintain 11-2 9 0
hydroxylation and 18-oxidation activity.
9 1
However, it is important to note that CYP11B2 did not specialize in the traditional sense 2 9 2
in that it did not lose one function in favor of another. It appears that it is necessary that in order 2 9 3
to increase 18-oxidation activity, there must also be an increase in 11β-hydroxylation activity.
9 4
Therefore, I dissected the substitutions from the preduplicated AncCYP11B to AncCYP11B2 to 2 9 5
understand the interplay of balancing 18-oxidation and 11β-hydroxylation activities.
9 6
Substitutions leading to AncCYP11B2 2 9 7
To understand the trajectory of functional evolution in the CYP11B2 lineage, I 2 9 8
characterized the function of all intermediates from AncCYP11B to AncCYP11B2. There are 2 9 9
four substitutions along this lineage. I dissected the effect of those substitutions by 3 0 0 characterizing the 11β-hydroxylase (Fig 4A) and 18-oxidation (Fig 4B) functions of all 16 3 0 1
combinations. All four substitutions appear to affect either 11β-hydroxylation or 18-oxidation 3 0 2 activity (Fig 4) . Here I depict ancestral character states as lowercase and derived as uppercase Here I studied the evolution of the corticosteroid synthesis pathway to determine how 3 2 2 functional evolution is resolved for a multi-step enzyme after duplication. The corticosteroids are 3 2 3 a crucial pathway, the products of which control metabolism, salt balance, and immunity among 3 2 4
other processes. To understand the processes that shape the augmentation of this pathway 3 2 5
(two enzymes that do the job of one), I used ancestral state reconstruction to resurrect enzymes 3 2 6
bracketing a gene duplication in the corticosteroid synthesis pathway in primates. Prior to its 3 2 7 duplication, the AncCYP11B enzyme had moderate activity on both the 11β-or 18-carbon of the 3 2 8
precursor DOC. Following duplication, while the CYP11B1 paralog specialized on 11β-carbon 3 2 9
activity, CYP11B2 maintained multiple functions, similar to the that of AncCYP11B, but 3 3 0 increased.
1
As biochemical pathways evolve, both mechanistic enzymatic and tissue-specific 3 3 2 constraints shape their evolution. Previous biochemical studies have established that CYP11B 3 3 3
11β-hydroxylation activity occurs first followed by 18-oxidation (Kominami, Harada, and 3 3 4
Takemori 1994). However, if the 11β-hydroxylated substrate (i.e. corticosterone) leaves the 3 3 5
active site, it cannot reenter to be 18-oxidized to aldosterone. This implies that in order to have
tissue-specific expression of CYP11B duplicates and still maintain zonation, CYP11B2 must 3 3 7 maintain both functions rather than specializing on 18-oxdiation activity. Our results that 3 3 8
consider the ancestral CYP11B activity help explain why CYP11B2 is constrained to maintain 3 3 9
11-hydroxylation activity in addition to 18-oxidation even when the conserved function of the zG 3 4 0 is to produce 18-hydroxylated products.
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